Literature DB >> 2450234

Serum cholesterol during ketanserin and propranolol administration in hypertensive patients.

P Lijnen1, R Fagard, J Staessen, V Blaton, P Hollez, G Rorive, A Amery.   

Abstract

The effect of ketanserin and propranolol on the serum total cholesterol (TC), and high-density lipoprotein (HDL-C) and low-density lipoprotein (LDL-C) cholesterol was studied in hypertensive patients treated for 3 months. During ketanserin administration, LDL-C decreased, whereas HDL-C and the HDL-C/LDL-C ratio increased and no significant effect in serum total cholesterol occurred. During propranolol administration, no significant effect was observed on serum total cholesterol, HDL-C and LDL-C, but the ratio of HDL-C/LDL-C increased. Intergroup comparison showed a greater increase in HDL-C (p less than 0.05) and in the HDL-C/LDL-C ratio (p less than 0.01) in the ketanserin group as compared with the propranolol group.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2450234     DOI: 10.1097/00005344-198712000-00007

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  5 in total

Review 1.  Ketanserin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in hypertension and peripheral vascular disease.

Authors:  R N Brogden; E M Sorkin
Journal:  Drugs       Date:  1990-12       Impact factor: 9.546

2.  Effects of ketanserin tartrate on serum lipids in patients with essential hypertension.

Authors:  H Nakamura; F Hirata; T Yasugi; M Mizuno; E Saito; T Ishikawa; N Tada; N Nakaya; Y Homma; I Takeuchi
Journal:  Drugs       Date:  1988       Impact factor: 9.546

3.  Effect of ketanserin on lipoproteins in patients with essential hypertension.

Authors:  K Arakawa; J Sasaki; K Saku; S Ideishi; Y Saeki; K Baba; K Ikeda; Y Kato; H Ohba; H Doi
Journal:  Drugs       Date:  1988       Impact factor: 9.546

4.  Hypertensive patients with Raynaud's phenomenon or intermittent claudication and their treatment with ketanserin.

Authors:  J C van Oene
Journal:  Drugs       Date:  1988       Impact factor: 9.546

5.  Effect of ketanserin tartrate on HMG CoA reductase and LDL receptor activity in cultured human skin fibroblasts.

Authors:  M Suzukawa; H Nakamura
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.